Abstract:Background: Lung cancer remains the leading cause of cancer deaths across the world. Early detection of lung cancer by low-dose computed tomography (LDCT) can reduce the mortality rate. However, making a definitive preoperative diagnosis of malignant pulmonary nodules (PNs) found by LDCT is a clinical challenge. This study aimed to develop a prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant pulmonary nodules from benign PNs. Methods: We assessed three DNA methylation biomarkers (PTGER4, RASSF1A, and SHOX2) and clinically-relevant variables in a training cohort of 110 individuals with PNs. Four machine-learning-based prediction models were established and compared, including the K-nearest neighbors (KNN), random forest (RF), support vector machine (SVM), and logistic regression (LR) algorithms. Variables of the best-performing algorithm (LR) were selected through stepwise use of Akaike's information criterion (AIC). The constructed prediction model was compared with the methylation biomarkers and the Mayo Clinic model using the non-parametric approach of DeLong et al. with the area under a receiver operator characteristic curve (AUC) analysis. Results: A prediction model was finally constructed based on three DNA methylation biomarkers and one radiological characteristic for identifying malignant from benign PNs. The developed prediction model achieved an AUC value of 0.951 in malignant PNs diagnosis, significantly higher than the three DNA methylation biomarkers (0.912, 95% CI:0.843-0.958, p = 0.013) or Mayo Clinic model (0.823, 95% CI:0.739-0.890, p = 0.001). Validation of the prediction model in the testing cohort of 100 subjects with PNs confirmed the diagnostic value. Conclusion: We have shown that integrating DNA methylation biomarkers and radiological characteristics could more accurately identify lung cancer in subjects with CT-found PNs. The prediction model developed in our study may provide clinical utility in combination with LDCT to improve the over-all diagnosis of lung cancer.

Predicting locus-specific DNA methylation levels in cancer and paracancer tissues

Diagnostic classification of cancers using DNA methylation of paracancerous tissues

Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis

A new parsimonious method for classifying Cancer Tissue-of-Origin Based on DNA Methylation 450K data

Accurate Prediction of Pan-Cancer Types Using Machine Learning with Minimal Number of DNA Methylation Sites.

Wemics: A Single‐Base Resolution Methylation Quantification Method for Enhanced Prediction of Epigenetic Regulation

Integrating muti-omics data to identify tissue-specific DNA methylation biomarkers for cancer risk

Predicting DNA methylation level across human tissues

DNA Methylation Markers for Pan-Cancer Prediction by Deep Learning

Discriminating Origin Tissues of Tumor Cell Lines by Methylation Signatures and Dys-Methylated Rules

Screening Dys-Methylation Genes and Rules for Cancer Diagnosis by Using the Pan-Cancer Study

Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers

Discovery and validation of colorectal cancer tissue-specific methylation markers: a dual-center retrospective cohort study

Robust prediction of gene regulation in colorectal cancer tissues from DNA methylation profiles

The Identification of Specific Methylation Patterns across Different Cancers

A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules

Predicting Cancer Tissue-of-Origin by a Machine Learning Method Using DNA Somatic Mutation Data.

Diagnostic classification based on DNA methylation profiles using sequential machine learning approaches.

Evaluating methylation of human ribosomal DNA at each CpG site reveals its utility for cancer detection using cell-free DNA

Identification of a CpG-based signature coupled with gene expression as prognostic indicators for melanoma: a preliminary study

A machine learning-based method for feature reduction of methylation data for the classification of cancer tissue origin